EUDAW — EUDA Health Holdings Ltd
—
Nasdaq ·
Health Care ·
Health Care Providers & Services ·
CIK 1847846 ·
Singapore
Last close
—
Market Cap
—
52W High
—
52W Low
—
ADV30
—
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | GrossProfit | OpIncome | NetIncome | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Dec 2025 | — | — | — | — | 1,716,562 | 345,145 | 5,984,084 |
| Dec 2024 | — | — | — | — | 1,697,810 | 237,605 | 4,269,878 |
Balance + Analyst (yfinance extras)
Retained Earnings
$-52,873,188
Inventory
$2,844
Receivables
$334,202
ST Investments
—
EBIT TTM
—
Pretax Income TTM
—
Interest Exp TTM
—
Analysts
—
Yahoo Snapshot (yfinance, live)
Total Revenue
$6,820,264
EBITDA
$-2,236,242
Free Cash Flow
$-953,881
Enterprise Value
—
Total Cash
$345,145
Total Debt
$2,401,371
Shares Out
—
Trailing EPS
—
Book Value
$-2.25
ROE
—
ROA
-89.3%
Div Yield
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | OpIncome | NetIncome | Assets | Liabilities | Equity | OCF |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 6,820,264 | -2,440,512 | -2,772,762 | 1,716,562 | 5,984,084 | — | -2,426,535 |
| Dec 2024 | 4,011,005 | -2,579,571 | -15,357,156 | 1,697,810 | 4,269,878 | — | -2,034,727 |
| Dec 2023 | 3,706,458 | -3,961,054 | -10,039,481 | 1,310,508 | 8,792,444 | — | -2,917,895 |
| Dec 2022 | 3,764,295 | -5,880,612 | -24,884,122 | 25,629,040 | 29,136,071 | — | -1,526,828 |
| Dec 2021 | — | — | — | — | — | — | — |
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| HCA | HCA Healthcare, Inc. | $86.51B | $389.97 | — |
| NTRA | Natera, Inc. | $31.07B | $216.97 | — |
| DGX | QUEST DIAGNOSTICS INC | $22.38B | $202.18 | — |
| LH | LABCORP HOLDINGS INC. | $21.73B | $265.03 | — |
| GH | Guardant Health, Inc. | $17.21B | $129.82 | — |
News headlines (Yahoo Finance, 1h cache)
EUDA Health Expands Helixé Product Line with Launch of Regenixé iPSC-Derived Skin Stem Cell Secretome Mask
2026-06-01 10:05 · Yahoo
EUDA Health Regains Compliance with Nasdaq Continued Listing Requirements After Receipt of Nasdaq Notification Regarding Minimum Market Value Deficiency
2026-06-01 10:00 · Yahoo
EUDA Highlights Shenzhen Inno’s Approval Under Shenzhen Key Industry R&D Program for TCR-T Cell Therapy Development
2026-04-28 10:00 · Yahoo
EUDA Health Holdings Limited Has Received Notice from Nasdaq that it has Failed to Maintain a Minimum Market Value of its Listed Securities
2026-04-27 10:00 · Yahoo
EUDA Announces Reverse Stock Split of its Ordinary Shares
2026-03-19 09:30 · Yahoo
EUDA Subsidiary CK Health Plus Expands into India in Strategic Partnership with SafeRock India
2025-10-23 13:00 · Yahoo
EUDA Subsidiary CK Health Plus Secures Malaysia Direct Selling License, Strengthening Its Longevity Business Across Asia
2025-10-20 13:00 · Yahoo
EUDA Signs Letter of Intent to Potentially Acquire GO POSB
2025-09-10 13:30 · Yahoo
EUDA Strategically Expands into T-Cell Immunotherapy – Strengthening Its Stem Cell Therapy Portfolio
2025-09-04 12:00 · Yahoo
EUDA Signs Letter of Intent to Potentially Acquire Chemokine Pte Ltd
2025-08-28 12:00 · Yahoo
Recent Insider Activity
No insider activity indexed for this ticker.